1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Liver Diseases in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (20.00) | 18.7374 |
| 1990's | 5 (50.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koizumi, T; Kubo, K; Kurata, Y; Ogura, T; Ruan, Z; Shibamoto, T; Shimo, T; Tsuchida, H | 1 |
| Basayiannis, AC; Demopoulos, CA; Grypioti, AD; Mykoniatis, MG; Papadimas, GK; Papadopoulou-Daifoti, Z; Theocharis, SE | 1 |
| Kang, GF; Liu, Y | 1 |
| Ackerman, Z; Amir, G; Karmeli, F; Rachmilewitz, D | 1 |
| Bailie, MB; Fink, GD; Pearson, JM; Roth, RA | 1 |
| Bzeizi, KI; Hayes, PC; Jalan, R; Plevris, JN | 1 |
| Baba, S; Ichiyama, A; Nakamura, S; Oda, T; Okamoto, T; Sakaguchi, T; Suzuki, S | 1 |
| Isaji, S; Izumi, T; Mizuno, S | 1 |
| Ichikawa, Y; Kioka, K; Kobayashi, K; Kuboi, H; Mizoguchi, Y; Morisawa, S; Sakagami, Y; Shin, T; Yamamoto, S | 1 |
| Alberton, M; Camussi, G; Coda, R; Macchiorlatti, E; Mariano, F; Montrucchio, G; Mularoni, E; Roffinello, C; Tetta, C | 1 |
2 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Liver Diseases
| Article | Year |
|---|---|
[Lipid mediators and liver injury].
Topics: Animals; Leukotrienes; Liver Diseases; Platelet Activating Factor; Prostaglandins | 1995 |
Primary graft dysfunction after liver transplantation: from pathogenesis to prevention.
Topics: Endothelins; Graft Rejection; Graft Survival; Humans; Kupffer Cells; Leukotrienes; Liver Diseases; Liver Transplantation; Neutrophils; Nitric Oxide; Organ Preservation; Platelet Activating Factor; Reactive Oxygen Species; Reperfusion Injury; Tissue Donors | 1997 |
8 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Liver Diseases
| Article | Year |
|---|---|
Effects of platelet-activating factor and thromboxane A2 on isolated perfused guinea pig liver.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Bile; Capillary Permeability; Guinea Pigs; In Vitro Techniques; Infusion Pumps; Liver; Liver Circulation; Liver Diseases; Male; Organ Size; Platelet Activating Factor; Portal Vein; Reperfusion Injury; Thromboxane A2; Vascular Resistance; Vasoconstriction; Vasoconstrictor Agents | 2004 |
Platelet-activating factor (PAF) involvement in acetaminophen-induced liver toxicity and regeneration.
Topics: Acetaminophen; Acetyltransferases; Analgesics, Non-Narcotic; Animals; Apoptosis; Chemical and Drug Induced Liver Injury; DNA; Hepatocytes; Liver Diseases; Liver Regeneration; Male; Mitotic Index; Platelet Activating Factor; Rats; Rats, Wistar; Thymidine Kinase; Time Factors | 2005 |
Gastric and colonic inflammatory and vasoactive mediators in experimental portal hypertension.
Topics: Animals; Bile Ducts; Colon; Eicosanoids; Endothelin-1; Gastric Mucosa; Hemodynamics; Hypertension, Portal; Intestinal Mucosa; Ligation; Liver Diseases; Male; Platelet Activating Factor; Portal Vein; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Stomach | 1996 |
Neither platelet activating factor nor leukotrienes are critical mediators of liver injury after lipopolysaccharide administration.
Topics: Administration, Oral; Alanine Transaminase; Animals; Azepines; Blood Platelets; Chemical and Drug Induced Liver Injury; Female; Fibrinogen; Hydroxyurea; Injections, Intraperitoneal; Injections, Intravenous; Leukotrienes; Lipopolysaccharides; Lipoxygenase Inhibitors; Liver; Liver Diseases; Necrosis; Neutrophils; Platelet Activating Factor; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Thrombocytopenia; Triazoles | 1997 |
Participation of platelet-activating factor in the lipopolysaccharide-induced liver injury in partially hepatectomized rats.
Topics: Alanine Transaminase; Animals; Chemical and Drug Induced Liver Injury; Chemokines, CXC; Chemotactic Factors; Electrophoresis; Growth Substances; Hepatectomy; Immunologic Techniques; Intercellular Signaling Peptides and Proteins; Kupffer Cells; Lipopolysaccharides; Liver; Liver Diseases; Liver Regeneration; Male; NF-kappa B; Platelet Activating Factor; Platelet Membrane Glycoproteins; Rats; Rats, Wistar; Receptors, Cell Surface; Receptors, G-Protein-Coupled; RNA, Messenger; Survival Analysis; Tumor Necrosis Factor-alpha | 1999 |
Role of PAF in acute liver injury after extended hepatectomy: overexpression of PAF receptor mRNA in Kupffer cells.
Topics: Acute Disease; Animals; Gene Expression Regulation; Hepatectomy; Kupffer Cells; Liver Diseases; Male; Platelet Activating Factor; Platelet Membrane Glycoproteins; Rats; Rats, Wistar; Receptors, Cell Surface; Receptors, G-Protein-Coupled; RNA, Messenger | 2001 |
[Changes in production of platelet activating factor by adherent hepatocytes of mice with experimental liver failure].
Topics: Acute Disease; Animals; Liver; Liver Diseases; Male; Mice; Platelet Activating Factor; Propionibacterium acnes | 1989 |
The role of platelet-activating factor in experimental immune complex pathology.
Topics: Animals; Antigen-Antibody Complex; Blood Vessels; Capillary Permeability; Chemical and Drug Induced Liver Injury; Complement C3; Female; Heart Diseases; Immune Complex Diseases; Kidney Diseases; Liver Diseases; Lung Diseases; Male; Platelet Activating Factor; Rabbits | 1985 |